Overview On Substance Induced Mood Disorders
Life Sciences-Substance Induced Mood Disorders
DOI:
https://doi.org/10.22376/ijpbs/lpr.2022.12.6.SP24.L64-73Keywords:
Mood Disorders, Medication, Drug, Mental Disorders, DepressiveAbstract
Despite the fact that both illegal drugs and iatrogenic pharmaceuticals are taken with the intention of improving mood, a sizeable percentage of patients actually have paradoxical affective problems as a result of taking those prescriptions. Some people have manic or depressive episodes instead of the banal bliss that comes with drinking or the "hangover" the next day. Substanceinduced mood disorders are those that only manifest in conjunction with substance use. Bipolar disorder and its related disorders, as well as depressive disorders, are examples of affective disorders that can develop in the context of substance use. Previously, these diseases may be found in the DSM-nosological IV's category of substance-induced mood disorders. However, "substanceinduced" is now a qualifier for mood disorders in the most recent DSM. In the general population, substance use disorders (SUDs) and depression and bipolar illness usually co-occur. The aim of this review is discussing substance-induced depressive disorder, substance-induced bipolar disorder, and related diseases. It will also go into further detail on how to tell them apart from mood disorders that co-occur with SUDs. Although it is no longer a separate category in the DSM-V, the term "substance-induced mood disorders" will be used to refer to both substance-induced depression and bipolar disorders for the purposes of this review. And the main objective is to collect research and review articles using trusted data base.
References
Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on alcohol and Related Conditions. Arch Gen Psychiatry. 2004 Aug;61(8):807-16. doi: 10.1001/archpsyc.61.8.807, PMID 15289279.
Tolliver BK, Anton RF. Assessment and treatment of mood disorders in the context of substance abuse. Dial Clin Neurosci. 2015 Jun;17(2):181-90. doi: 10.31887/DCNS.2015.17.2/btolliver, PMID 26246792.
Helzer JE, Pryzbeck TR. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol. 1988;49(3):219-24. doi: 10.15288/jsa.1988.49.219, PMID 3374135.
Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National comorbidity Survey. Arch Gen Psychiatry. 1997;54(4):313-21. doi: 10.1001/archpsyc.1997.01830160031005, PMID 9107147.
Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) Study. JAMA. 1990;264(19):2511-18, PMID 2232018.
Volkow ND. The reality of comorbidity: depression and drug abuse. Biol Psychiatry. 2004;56(10):714-7. doi: 10.1016/j.biopsych.2004.07.007, PMID 15556111.
Quello SB, Brady KT, Sonne SC. Mood disorders and substance use disorder: a complex comorbidity. Sci Pract Perspect. 2005 Dec;3(1):13-21. doi: 10.1151/spp053113, PMID 18552741, PMCID PMC2851027.
Brown SA, Inaba RK, Gillin JC, Schuckit MA, Stewart MA, Irwin MR. Alcoholism and affective disorder: clinical course of depressive symptoms. Am J Psychiatry. 1995 Jan;152(1):45-52. doi: 10.1176/ajp.152.1.45, PMID 7802119.
Davidson KM. Diagnosis of depression in alcohol dependence: changes in prevalence with drinking status. Br J Psychiatry. 1995 Feb;166(2):199-204. doi: 10.1192/bjp.166.2.199, PMID 7728364.
Schuckit MA, Smith TL, Danko GP, Pierson J, Trim R, Nurnberger JI et al. A comparison of factors associated with substance-induced versus independent depressions. J Stud Alcohol Drugs. 2007 Nov;68(6):805-12. doi: 10.15288/jsad.2007.68.805, PMID 17960298.
Patten SB, Barbui C. Drug-induced depression: a systematic review to inform clinical practice. Psychother Psychosom. 2004 Jul-Aug;73(4):207-15. doi: 10.1159/000077739, PMID 15184715.
Anisman H, Kokkinidis L, Merali Z. Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes. Brain Behav Immun. 2002 Oct;16(5):544-56. doi: 10.1016/s0889-1591(02)00011-9, PMID 12401468.
Markou A, Kosten TR, Koob GF. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology. 1998 Mar;18(3):135-74. doi: 10.1016/S0893-133X(97)00113-9, PMID 9471114.
Peroutka SJ, Snyder SH. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science. 1980 Oct 03;210(4465):88-90. doi: 10.1126/science.6251550, PMID 6251550.
Parsons LH, Smith AD, Justice JB. Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine. Synapse. 1991 Sep;9(1):60-5. doi: 10.1002/syn.890090109, PMID 1796352.
Kosten TR, Markou A, Koob GF. Depression and stimulant dependence: neurobiology and pharmacotherapy. J Nerv Ment Dis. 1998 Dec;186(12):737-45. doi: 10.1097/00005053-199812000-00001, PMID 9865811.
Blanco C, Alegría AA, Liu SM, Secades-Villa R, Sugaya L, Davies C et al. Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: results from the National Epidemiologic Survey on alcohol and Related Conditions. J Clin Psychiatry. 2012 Jun;73(6):865-73. doi: 10.4088/JCP.10m06673, PMID 22480900.
Gilder DA, Wall TL, Ehlers CL. Comorbidity of select anxiety and affective disorders with alcohol dependence in southwest California Indians. Alcohol Clin Exp Res. 2004 Dec;28(12):1805-13. doi: 10.1097/01.alc.0000148116.27875.b0, PMID 15608596.
Hesselbrock M, Easton C, Bucholz KK, Schuckit M, Hesselbrock V. A validity study of the SSAGA--a comparison with the SCAN. Addiction. 1999 Sep;94(9):1361-70. doi: 10.1046/j.1360-0443.1999.94913618.x, PMID 10615721.
Ahmadi J, Majdi B, Mahdavi S, Mohagheghzadeh M. Mood disorders in opioid-dependent patients. J Affect Disord. 2004 Oct 01;82(1):139-42. doi: 10.1016/j.jad.2003.09.015, PMID 15465588.
Myrick H, Cluver J, Swavely S, Peters H. Diagnosis and treatment of co-occurring affective disorders and substance use disorders. Psychiatr Clin North Am. 2004 Dec;27(4):649-59. doi: 10.1016/j.psc.2004.06.003, PMID 15550285.
Markou A, Kosten TR, Koob GF. Neurobiological similarities in depression and drug dependence: A self-medication hypothesis. Neuropsychopharmacology. 1998;18(3):135-74. doi: 10.1016/S0893-133X(97)00113-9, PMID 9471114.
Post RM, Rubinow DR, Ballenger JC. Conditioning, sensitization, and kindling: Implications for the course of affective illness. In: Post RM, Ballenger JC, editors. Neurobiology of mood disorders. Baltimore: Williams & Wilkins; 1984. p. 432-66.
Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry. 2005 Jan;62(1):37-45. doi: 10.1001/archpsyc.62.1.37, PMID 15630071.
Salloum IM, Douaihy A, Cornelius JR, Kirisci L, Kelly TM, Hayes J. Divalproex utility in bipolar disorder with co-occurring cocaine dependence: a pilot study. Addict Behav. 2007 Feb;32(2):410-5. doi: 10.1016/j.addbeh.2006.05.007, PMID 16814474.
Brown ES, Nejtek VA, Perantie DC, Bobadilla L. Quetiapine in bipolar disorder and cocaine dependence. Bipolar Disord. 2002 Dec;4(6):406-11. doi: 10.1034/j.1399-5618.2002.02229.x, PMID 12519101.
Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89-95. doi: 10.1067/mcp.2001.113989, PMID 11240971.
De Leon G, Skodol A, Rosenthal MS. Phoenix House: Changes in psychopathological signs of resident drug addicts. Arch Gen Psychiatry. 1973;28(1):131-5. doi: 10.1001/archpsyc.1973.01750310103017, PMID 4405119.
Brown SA, Schuckit MA. Changes in depression among abstinent alcoholics. J Stud Alcohol. 1988;49(5):412-7. doi: 10.15288/jsa.1988.49.412, PMID 3216643.
Schuckit MA. The clinical implications of primary diagnostic groups among alcoholics. Arch Gen Psychiatry. 1985;42(11):1043-9. doi: 10.1001/archpsyc.1985.01790340021003, PMID 4051681.
Schuckit MA. Genetic and clinical implications of alcoholism and affective disorder. Am J Psychiatry. 1986;143(2):140-7. doi: 10.1176/ajp.143.2.140, PMID 3511739.
Goldberg JF, Garno JL, Callahan AM, Kearns DL, Kerner B, Ackerman SH. Overdiagnosis of bipolar disorder among substance use disorder inpatients with mood instability. J Clin Psychiatry. 2008;69(11):1751-7. doi: 10.4088/jcp.v69n1110, PMID 18945397.
Albanese MJ, Clodfelter RC, Pardo TB, Ghaemi SN. Underdiagnosis of bipolar disorder in men with substance use disorder. J Psychiatr Pract. 2006;12(2):124-7. doi: 10.1097/00131746-200603000-00010, PMID 16728911.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
Kiefer F, Jahn H, Tarnaske T, Helwig H, Briken P, Holzbach R, et al. Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a doubleblind, placebo-controlled study. Arch Gen Psychiatry. 2003;60(1):92-9. doi: 10.1001/archpsyc.60.1.92, PMID 12511176.
Greenfield SF, Weiss RD, Muenz LR, Vagge LM, Kelly JF, Bello LR, et al. The effect of depression on return to drinking: a prospective study. Arch Gen Psychiatry. 1998;55(3):259-65. doi: 10.1001/archpsyc.55.3.259, PMID 9510220.
Litten RZ, Bradley AM, Moss HB. Alcohol biomarkers in applied settings: recent advances and future research opportunities. Alcohol Clin Exp Res. 2010;34(6):955-67. doi: 10.1111/j.1530-0277.2010.01170.x, PMID 20374219.
Ramsey SE, Kahler CW, Read JP, Stuart GL, Brown RA. Discriminating between substance-induced and independent depressive episodes in alcohol-dependent patients. J Stud Alcohol. 2004;65(5):672-6. doi: 10.15288/jsa.2004.65.672, PMID 15536779.
Nunes EV, Liu X, Samet S, Matseoane K, Hasin D. Independent versus substance-induced major depressive disorder in substance-dependent patients: Observational study of course during follow-up. J Clin Psychiatry. 2006;67(10):1561-7. doi: 10.4088/jcp.v67n1010, PMID 17107247.
Blanco C, Alegría AA, Liu SM, Secades-Villa R, Sugaya L, Davies C, et al. Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: Results from the National Epidemiologic Survey on alcohol and Related Conditions. J Clin Psychiatry. 2012;73(6):865-73. doi: 10.4088/JCP.10m06673, PMID 22480900.
DelBello MP, Hanseman D, Adler CM, Fleck DE, Strakowski SM. Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. Am J Psychiatry. 2007;164(4):582-90. doi: 10.1176/ajp.2007.164.4.582, PMID 17403971.
Strakowski SM, DelBello MP, Fleck DE, Adler CM, Anthenelli RM, Keck PE, et al. Effects of co-occurring alcohol abuse on the course of bipolar disorder following first hospitalization for mania. Arch Gen Psychiatry. 2005;62(8):851-8. doi: 10.1001/archpsyc.62.8.851, PMID 16061762.
41, van Zaane J, van den Brink W, Draisma S, Smit JH, Nolen WA. The effect of moderate and excessive alcohol use on the course and outcome of patients with bipolar disorders: a prospective cohort study. J Clin Psychiatry. 2010;71(7):885-93. doi: 10.4088/JCP.09m05079gry, PMID 20122372.
Drake RE, Xie H, McHugo GJ, Shumway M. Three-year outcomes of long-term patients with co-occurring bipolar and substance use disorders. Biol Psychiatry. 2004;56(10):749-56. doi: 10.1016/j.biopsych.2004.08.020, PMID 15556119.
Farren CK, Murphy P, McElroy S. A 5-year follow-up of depressed and bipolar patients with alcohol use disorder in an Irish population. Alcohol Clin Exp Res. 2014;38(4):1049-58. doi: 10.1111/acer.12330, PMID 24428168.
Available from: https://www.ebsco.com/sites/g/files/nabnos191/files/acquiadam-assets/Social-Work-Reference-Center-Quick-Lesson-Bipolar-Disorders.pdf.
Weiss RD, Griffin ML, Kolodziej ME, Greenfield SF, Najavits LM, Daley DC, et al. A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. Am J Psychiatry. 2007;164(1):100-7. doi: 10.1176/ajp.2007.164.1.100, PMID 17202550.
Pettinati HM, O’Brien CP, Dundon WD. Current status of co-occurring mood and substance use disorders: a new therapeutic target. Am J Psychiatry. 2013;170(1):23-30. doi: 10.1176/appi.ajp.2012.12010112, PMID 23223834.
Pettinati HM. Antidepressant treatment of co-occurring depression and alcohol dependence. Biol Psychiatry. 2004;56(10):785-92. doi: 10.1016/j.biopsych.2004.07.016, PMID 15556124.
Kranzler HR, Mueller T, Cornelius J, Pettinati HM, Moak D, Martin PR, et al. Sertraline treatment of co-occurring alcohol dependence and major depression. J Clin Psychopharmacol. 2006;26(1):13-20. doi: 10.1097/01.jcp.0000194620.61868.35, PMID 16415699.
Pettinati HM, Oslin DW, Kampman KM, Dundon WD, Xie H, Gallis TL, et al. A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. Am J Psychiatry. 2010;167(6):668-75. doi: 10.1176/appi.ajp.2009.08060852, PMID 20231324.
Moak DH, Anton RF, Latham PK, Voronin KE, Waid RL, Durazo-Arvizu R. Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial. J Clin Psychopharmacol. 2003;23(6):553-62. doi: 10.1097/01.jcp.0000095346.32154.41, PMID 14624185.
Brown ES, Sunderajan P, Hu LT, Sowell SM, Carmody TJ. A randomized, double-blind, placebo-controlled trial of lamotrigine therapy in bipolar disorder, depressed or mixed phase and cocaine dependence. Neuropsychopharmacology. 2012;37(11):2347-54. doi: 10.1038/npp.2012.90, PMID 22669171.
Brown ES, Gorman AR, Hynan LS. A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence. J Clin Psychopharmacol. 2007;27(5):498-502. doi: 10.1097/JCP.0b013e31814db4c4, PMID 17873684.
Knudsen HK, Abraham AJ, Roman PM. Adoption and implementation of medications in addiction treatment programs. J Addict Med. 2011;5(1):21-7. doi: 10.1097/ADM.0b013e3181d41ddb, PMID 21359109.
Simon NM, Otto MW, Weiss RD, Bauer MS, Miyahara S, Wisniewski SR et al. Pharmacotherapy for bipolar disorder and comorbid conditions. Baseline data from STEP-BD. J Clin Psychopharmacol. 2004;24(5):512-20. doi: 10.1097/01.jcp.0000138772.40515.70, PMID 15349007.
Diaz FJ, James D, Botts S, Maw L, Susce MT, de Leon J. Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression. Bipolar Disord. 2009;11(2):154-65. doi: 10.1111/j.1399-5618.2009.00664.x, PMID 19267698.
Thorndike AN, Stafford RS, Rigotti NA. US physicians’ treatment of smoking in outpatients with psychiatric diagnoses. Nicotine Tob Res. 2001;3(1):85-91. doi: 10.1080/14622200020032132, PMID 11260815.
Conner KR, Gamble SA, Bagge CL, He H, Swogger MT, Watts A et al. Substance-induced depression and independent depression in proximal risk for suicidal behavior. J Stud Alcohol Drugs. 2014 Jul;75(4):567-72. doi: 10.15288/jsad.2014.75.567, PMID 24988255.
Available from: https://europepmc.org/article/nbk/nbk555887#_article-29642_s11_.
Published
How to Cite
Issue
Section
Copyright (c) 2022 Najlaa Mohammad Alsudairy, Ibrahim Abdullah Almuqrin, Abdulrahman Ali Shukr, Manal Manajaa Alotaibi, Asma Ahmed Hassan Alghamdi, Wajdi Ibarahim Abbas, Joraid Hussam Abdullah A, Alanazi Abdullah Tban M, Abdullah Mohammedhussain , Dimah Mohammed A Abu Murad, Al Sharyah Salem Mohammed S, Turki Abdullah Aldalaan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.